Cardioxane 500mg powder for solution for infusion

Product name and form

CARDIOXANE 500mg, powder for solution for infusion.

Pharmaceutical Form

Powder for solution for infusion.

Sterile, pyrogen free, white to off-white, lyophilised powder.

Qualitative and quantitative composition

Dexrazoxane 500.00mg as its hydrochloride salt.

For a vial of powder.

For a full list of excipients, see section 6.1.

List of Excipients

Not applicable.

Pack sizes and marketing

Vials (Type I brown glass), containing 500 mg of powder, closed with a chlorobutyl rubber stopper and an aluminium cap with pre-cut strip. The product is further enclosed in an outer carton. It is supplied in packs of 1 and 4 vials. Not all pack sizes may be marketed.

Marketing authorization holder

Novartis Pharmaceuticals UK Limited
Frimley Business Park
Frimley
Camberley
Surrey
GU16 7SR

Marketing authorization dates and numbers

PL 00101/0937

1 September 2006 / 16 February 2012

Drugs

Drug
Countries
Brazil, Spain, France, Hong Kong, Netherlands, Poland, United Kingdom